-
C127870-5mgCarfilzomib (PR-171) is an irreversible proteasome inhibitor with IC50 of <:5 nM, displayed preferential in vitro inhibitory potency against the ChT-L activity in the β5 subunit, but little or no effect on the PGPH and T-L activities.Proteasome
-
C608324-25mgcarindacillin.
-
C608324-5mgcarindacillin.
-
C126186-25mgCariprazine(RGH188) is a novel antipsychotic drug candidate that exhibits high selectivity and affinity to dopamine D3(Ki=0.09 nM) and D2 (Ki=0.5 nM) receptors and moderate affinity to serotonin 5-HT(1A) receptors.
-
C126186-50mgCariprazine(RGH188) is a novel antipsychotic drug candidate that exhibits high selectivity and affinity to dopamine D3(Ki=0.09 nM) and D2 (Ki=0.5 nM) receptors and moderate affinity to serotonin 5-HT(1A) receptors.
-
C126186-5mgCariprazine(RGH188) is a novel antipsychotic drug candidate that exhibits high selectivity and affinity to dopamine D3(Ki=0.09 nM) and D2 (Ki=0.5 nM) receptors and moderate affinity to serotonin 5-HT(1A) receptors.
-
-
-
-
-
C608327-25mgcarotegrast methyl.
-
C608327-5mgcarotegrast methyl.